Despite the similarities in clinical and laboratory features in COVID-19 and AOSD, we are the first to identify IL-18 as a potential discriminator between active AOSD and severe COVID-19, with a high AUC (0.948), high sensitivity, and high specificity, as well as a significant predictor of active AOSD. This evidence concerns the gene IL18 and COVID-19.